Multiple Assemblies exist for SMTL entry 6fyz
Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor; X-RAY DIFFRACTION 2.15 Å

	SMTL ID 6fyz.1 Ligands (2~{S})-2-(2-fluorophenyl)-2-[4-(2-methylpyrimidin-5-yl)phenyl]-~{N}-oxidanyl-ethanamide; ZINC ION; SODIUM ION Polypeptides Histone deacetylase 4 Oligo-state monomer
	SMTL ID 6fyz.2 Ligands (2~{S})-2-(2-fluorophenyl)-2-[4-(2-methylpyrimidin-5-yl)phenyl]-~{N}-oxidanyl-ethanamide; ZINC ION; SODIUM ION Polypeptides Histone deacetylase 4 Oligo-state monomer
	SMTL ID 6fyz.3 Ligands (2~{S})-2-(2-fluorophenyl)-2-[4-(2-methylpyrimidin-5-yl)phenyl]-~{N}-oxidanyl-ethanamide; ZINC ION; SODIUM ION Polypeptides Histone deacetylase 4 Oligo-state monomer